Getinge B will, as a preliminary result of the semi-annual review, be included in the OMXS30-index as from July 1, 2009. The OMXS30 Index is one of Europe's most traded indexes and includes 30 of Sweden's most traded blue chip stocks. NASDAQ OMX Derivatives Markets will, due to the upcoming inclusion, list standardised options and forwards in Getinge. Listing of standardised series will be made as from June 15, 2009.
Getinge is a global medical technology company with operations in the areas of surgery, intensive care, infection control, care ergonomics and wound care. The Group is organised in three business areas: Medical Systems, Extended Care, and Infection Control.
Nordea Bank will be quoting prices for options and forwards in Getinge.
For further information, please see the attached document.
